期刊文献+

胃癌术后复发的临床分析 被引量:13

The management of postoperative recurrence of gastric carcinoma
原文传递
导出
摘要 目的研究胃癌术后复发的临床特点,总结处理经验。方法回顾性分析2002年1月至2008年12月收治的78例胃癌术后复发病例的临床资料。结果本组78例胃癌术后复发患者的中位复发时间为术后16.8个月。多因素分析显示首次手术的根治程度、切缘情况、肿瘤分化程度、TNM分期直接影响肿瘤的复发时间(P〈0.05)。术后复发转移部位与首次胃癌手术方式无明显关系(P〉0.05)。再手术36例,其中因单一肝转移行肝叶或肝段切除3例,因局部复发再手术33例。结论首次手术的根治程度、切缘情况、肿瘤分化程度、TNM分期是胃癌术后复发的主要因素。应根据具体情况采取包括手术在内的综合治疗积极措施,以改善患者的生活质量及预后。 Objective To study clinical characteristics of postoperative recurrence after a cure intent resection for gastric cancer. Methods From 2002 to 2008, 78 patients with recurrent cancer after curative gastrectomy for gastric cancer hospitalized in our department were enrolled in this study. Results The average recurrent time was 16. 8 months. The multi-factor analysis demonstrated that the original surgical parameters such as radical degree, incision margin, differentiation, TNM stages were all factors influencing the recurrent time ( P 〈 0. 05 ). There was no remarkable difference in recurrent positions among different surgical modalities ( P 〉 0. 05 ). Thirty-six patients received reoperation, of which 3 patients underwent hepatectomy for single liver metastasis, and 33 patients received resection for local recurrence. Conclusions Radical resection incision margin, tumor differentiation, TNM stages at the first surgery were factors influencing recurrent gastric carcinoma after resection. Tumor recurrence should be treated with comprehensive therapy including re-operation to improve the prognosis and quality of life.
出处 《中华普通外科杂志》 CSCD 北大核心 2010年第2期146-148,共3页 Chinese Journal of General Surgery
关键词 胃肿瘤 复发 病理学 临床 Stomach neoplasms Recurrence Pathology, clinical
  • 相关文献

参考文献7

  • 1Samson PS, Escovidal LA, Yrastorza SG, et al. Re-study of gastric cancer:analysls of outcome. World J Surg,2002 ,26 :428-433.
  • 2Schwarz RE, Zagala-Nevarez K. Recurence patterns after radical gastrectomy for gastric cancer:prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol, 2002,9: 394- 400.
  • 3邢福成,王殿昌,梁寒.胃癌根治术后早期和晚期复发因素分析[J].中国肿瘤临床与康复,2001,8(1):96-97. 被引量:8
  • 4Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric caroinoma. Br J Surg,2000 ,87 :236-242.
  • 5Wu CW, Lo SS, Shen KH, et al. Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer. World J Surg,2003,27 : 153-158.
  • 6Otsuji E, Kobayashi S, Okamoto K, et al. Is timing of death from tumor recurrence predictable after curative resection for gastric cancer? World J Surg,2001,25 :1373-1376.
  • 7王舒宝,王俊.胃癌复发与转移的有关问题及综合治疗[J].中国普外基础与临床杂志,2006,13(1):9-11. 被引量:33

二级参考文献25

  • 1戚晓东,邢承忠,王舒宝,齐春莲,张文范,陈峻青,王梅先.Borrmann 4型胃癌的临床病理特点及外科治疗效果的评价[J].实用肿瘤学杂志,1994,8(1):63-65. 被引量:6
  • 2陈峻青.胃癌根治术后复发形式和治疗方法的选择[J].中国实用外科杂志,1995,15(12):709-710. 被引量:55
  • 3刘庆华,陈峻青.胃癌腹腔内游离癌细胞与预后(附100例临床报告)[J].中国实用外科杂志,1996,16(10):616-617. 被引量:29
  • 4Tanabe K,Yoshida K,Hamai Y,et al.Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases [J].Gan To Kagaku Ryoho,2005;32(8):1145
  • 5Sakaguchi Y,Kabashima A,Okita K,et al.Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer [J].Gastric Cancer,2005;8(2):111
  • 6Johira H,Yunoki S,Kawata N,et al.Results of treatment of far advanced and recurrent stomach cancer with TS-1 [J].Gan To Kagaku Ryoho,2005;32(2):195
  • 7Yonemori K,Shimada Y,Goto A,et al.Retrospective analysis of clinical results and predictors of response in chemo-naive patients with advanced gastric cancer treated with S-1,an oral fluoropyrimidine derivative,as single-agent chemotherapy [J].Gastric Cancer,2004;7(4):204
  • 8Shin SJ,Chun SH,Kim KO,et al.The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer:a multicenter phase Ⅱ study [J].Korean J Intern Med,2005;20(2):135
  • 9Yeh KH,Lu YS,Hsu CH,et al.Phase Ⅱ study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer [J].Oncology,2005;69(1):88
  • 10Cho EK,Lee WK,Im SA,et al.A phase Ⅱ study of epirubicin,cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer [J].Oncology,2005;68(4-6):333

共引文献38

同被引文献83

引证文献13

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部